CD8A and neoplasm: In addition, we have observed that APG‐157 shows complete tumor cell growth suppression in SCCVII murine H&N cancer model when it is combined with anti‐CTLA‐4 antibody which is dependent on CD8+ T cells in the TME (Figure 5B).